BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38493218)

  • 1. HOXD3 promotes the migration and angiogenesis of hepatocellular carcinoma via modifying hepatocellular carcinoma cells exosome-delivered CCR6 and regulating chromatin conformation of CCL20.
    Wang L; Qiao C; Han L; Wang X; Miao J; Cao L; Huang C; Wang J
    Cell Death Dis; 2024 Mar; 15(3):221. PubMed ID: 38493218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
    Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
    Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
    Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
    Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma.
    Du D; Liu Y; Qian H; Zhang B; Tang X; Zhang T; Liu W
    Int J Mol Sci; 2014 Apr; 15(4):6441-52. PubMed ID: 24743888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXD3 was negatively regulated by YY1 recruiting HDAC1 to suppress progression of hepatocellular carcinoma cells via ITGA2 pathway.
    Wang L; Gao Y; Zhao X; Guo C; Wang X; Yang Y; Han C; Zhao L; Qin Y; Liu L; Huang C; Wang W
    Cell Prolif; 2020 Aug; 53(8):e12835. PubMed ID: 32557953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma.
    Qiu W; Wang G; Sun X; Ye J; Wei F; Shi X; Lv G
    Med Oncol; 2015 Mar; 32(3):75. PubMed ID: 25698534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells.
    Wang L; Tong D; Guo Q; Wang X; Wu F; Li Q; Yang J; Zhao L; Qin Y; Liu Y; Huang C
    Sci Rep; 2018 Feb; 8(1):2431. PubMed ID: 29402992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MeCP2 drives hepatocellular carcinoma progression via enforcing HOXD3 promoter methylation and expression through the HB-EGF/EGFR pathway.
    Wang L; Gao Y; Tong D; Wang X; Guo C; Guo B; Yang Y; Zhao L; Zhang J; Yang J; Qin Y; Liu L; Huang C
    Mol Oncol; 2021 Nov; 15(11):3147-3163. PubMed ID: 34028973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of chemotactic and pro-inflammatory activities of endothelial progenitor cells by hepatocellular carcinoma.
    Shih YT; Wang MC; Peng HH; Chen TF; Chen L; Chang JY; Chiu JJ
    Cell Signal; 2012 Mar; 24(3):779-93. PubMed ID: 22120522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
    Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma].
    Chang X; Wang L; Zang M; Rong W; Wu Z; Liu L; Du J; Liu J; Wu J; Qu C
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):5-10. PubMed ID: 25877311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization.
    Wang Y; Gao R; Li J; Tang S; Li S; Tong Q; Li S
    Int J Nanomedicine; 2021; 16():2803-2818. PubMed ID: 33880025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
    Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS
    PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.
    Li R; Wang Y; Zhang X; Feng M; Ma J; Li J; Yang X; Fang F; Xia Q; Zhang Z; Shang M; Jiang S
    Mol Cancer; 2019 Jan; 18(1):18. PubMed ID: 30704479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis.
    Huang XY; Huang ZL; Huang J; Xu B; Huang XY; Xu YH; Zhou J; Tang ZY
    J Exp Clin Cancer Res; 2020 Jan; 39(1):20. PubMed ID: 31973767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of exosomal CLEC3B in hepatocellular carcinoma promotes metastasis and angiogenesis via AMPK and VEGF signals.
    Dai W; Wang Y; Yang T; Wang J; Wu W; Gu J
    Cell Commun Signal; 2019 Sep; 17(1):113. PubMed ID: 31477130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA TRERNA1 facilitates hepatocellular carcinoma metastasis by dimethylating H3K9 in the CDH1 promoter region via the recruitment of the EHMT2/SNAI1 complex.
    Song W; Gu Y; Lu S; Wu H; Cheng Z; Hu J; Qian Y; Zheng Y; Fan H
    Cell Prolif; 2019 Jul; 52(4):e12621. PubMed ID: 31012192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
    Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H
    Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA ANCR promotes hepatocellular carcinoma metastasis through upregulating HNRNPA1 expression.
    Wen Z; Lian L; Ding H; Hu Y; Xiao Z; Xiong K; Yang Q
    RNA Biol; 2020 Mar; 17(3):381-394. PubMed ID: 31868085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR6
    He H; Wu J; Zang M; Wang W; Chang X; Chen X; Wang R; Wu Z; Wang L; Wang D; Lu F; Sun Z; Qu C
    Am J Cancer Res; 2017; 7(5):1151-1163. PubMed ID: 28560063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.